Drug-delivery tech developer AMW lands $30m from EU bank

Drug-delivery tech developer AMW has landed $30 million from the European Union’s lending institution to help fund the company’s development activities and expand production capacity.

The German pharmaceutical company’s newly-acquired funds will specifically support a new R&D facility located in Bavaria.

Get the full story at our sister site, Drug Delivery Business News.

The post Drug-delivery tech developer AMW lands $30m from EU bank appeared first on MassDevice.

The ‘smart pill’ market could be worth $3B by 2025 – meet the key players

The “smart pill” market is expected to nearly quadruple in value to $3 billion by 2025, according to Grand View Research. Driving this growth is an increasing demand for minimally-invasive procedures, as well as better patient monitoring capabilities.

There are a number of players in the pharmaceutical and medtech arenas looking to stake a claim to the smart pill market. The companies are segmented into two groups – those developing capsules used for endoscopy and those creating connected, swallowable drug-tracking systems.

Get the full story at our sister site, Drug Delivery Business News.

The post The ‘smart pill’ market could be worth $3B by 2025 – meet the key players appeared first on MassDevice.

Bellerophon brings inhaled nitric oxide into Ph2 pulmonary hypertension trial

Bellerophon Therapeutics (NSDQ:BLPH) has enrolled the first patient in a Phase IIb study assessing its INOpulse device in patients with pulmonary hypertension due to interstitial lung disease.

The company’s placebo-controlled study is slated to evaluate the safety and efficacy of pulsed, inhaled nitric oxide in patients with PH-ILD, including those with idiopathic pulmonary fibrosis, Bellerophon reported.

Get the full story at out sister site, Drug Delivery Business News.

The post Bellerophon brings inhaled nitric oxide into Ph2 pulmonary hypertension trial appeared first on MassDevice.

pSivida touts pilot osteoarthritis trial for Durasert implant

Share

pSividapSivida (NSDQ:PSDV) touted results today from a Phase I safety and efficacy pilot trial of its sustained-release Durasert implant in patients with osteoarthritis of the knee.

The company’s Durasert tech, combined with an implantable device from the Hospital for Special Surgery, was designed to continuously deliver a low dose of dexamethasone into the knee joint. Six patients with osteoarthritis of the knee were followed throughout the study for six months.

Get the full story at our sister site, Drug Delivery Business News.

Companion Medical launches smart insulin pen in U.S.

  • 7 medical devices combating the opioid crisis

    Opioid-related deaths have become an epidemic in the US, garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from a drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause […]

  • Companion Medical launches smart insulin pen in U.S.

    Companion Medical started selling its smart insulin pen in the U.S. today, according to the San Diego, Calif.-based company. The InPen system, which combines an insulin injector pen and a smartphone app, is compatible with Eli Lilly‘s (NYSE:LLY) Humalog and Novo Nordisk‘s (NYSE:NVO) Novolog fast-acting insulin. Get the full story at our sister site, Drug Delivery Business News. […]

  • Manufacturing companies form collaborative for advancing product development capabilities

    A group of manufacturing services companies said today they created a collaboration, called the Medical Device Development Collaborative, to help improve access to a full range of product development capabilities for concept-to-market solutions. The collaboration is based in the Medical Alley region and aims to help small to mid-size OEMs by offering experience and expertise […]

  • Millar offloads telemetry product line to Kaha Sciences

    Medical device and OEM company Millar said today it is selling its lifesciences telemetry product division to New Zealand-based Kaha Sciences. Houston-based Millar said the divestiture comes as the company looks to focus its efforts on the clinical and OEM business segments in a strategy that emerged earlier this year. Kaha Sciences has picked up a handful […]

  • InstruSafe and Senhance Surgical Robotic System partner to launch instrument trays

    Summit Medical’s InstruSafe and TransEnterix’s Senhance Surgical Robotic System  have forged a partnership to launch two new surgical instrument trays for use with the robotic platform. The two new trays will include an instrument tray an an endoscopic adapter tray, both of which have been validated for the Senhance instrumentation. “We are excited to expand our product offering […]

  • New FDA guidance for dual submission 510(k) and CLIA waiver application for IVD companies

    By Stewart Eisenhart, Emergo Group New guidance from the US Food and Drug Administration explains requirements for in vitro diagnostic manufacturers to register for premarket notification using the agency’s Dual 510(k) and Clinical Laboratory Improvement Amendments (CLIA) Waiver by Application. Get the full story here at the Emergo Group’s blog. The opinions expressed in this […]

  • Researchers create ultrasound-sensor powered prosthetic hand with individual digit control

    Researchers are one step closer to creating a prosthetic hand that allows users to have full control over each finger, according to a new report from Georgia Tech. Researchers at the university say they have created an ultrasonic sensor which allows amputees to control individual fingers on a prosthetic hand, with enough sensitivity to play […]

  • Medline acquires Centurion Medical Products

    Medline recently completed its previously announced acquisition of Centurion Medical Products – boosting offerings around the Medline Erase BSI line access and dressing change bundles. Financial terms of the deal were not disclosed. Medline’s Erase BSI is meant to standardize best practices around central lines post-insertion, reducing cases of bloodstream infections. On top of its minor procedure trays, Centurion makes vascular insertion […]

  • Cadence expands laser processing capabilities

    Cadence has expanded its laser processing technologies with a new CL900 Cincinnati laser cutting machine. The new 4,000W fiber laser cutter adds to Cadence’s modified tube cutting lasers and completely custom flat sheet cutting lasers, Cadence announced yesterday. It also has the ability to cut 1,000 in. per minute (IPM) with a positioning accuracy of +/-0.001 […]

  • These artificial heart muscle patches can repair dead heart muscles

    A team of biomedical engineers have developed a fully functioning artificial human heart muscle that can be used as a patch to repair dead heart muscle. Duke University biomedical engineers developed the patch to be used in human patients who have previously suffered a heart attack. “Right now, virtually all existing therapies are aimed at […]

  • How to think outside the box with medtech innovation

    Innovation is important in medtech and many other industries. But what does it really mean – and can it be done with speed? That was the question that a panel of experts – moderated by William Betten of Betten Solutions – grappled with today at DeviceTalks West in Orange County, Calif. It turns out that […]

  • Shire taps Rani Therapeutics’ oral delivery tech for hemophilia therapy

    Share

    ShireShire (NSDQ:SHPG) said this week that it is collaborating with Rani Therapeutics to combine the company’s Rani Pill technology for the delivery of factor VIII therapy in patients with hemophilia A.

    According to the terms of the deal, Shire has the exclusive option to negotiate a license to develop and commercialize the technology as a delivery mechanism for FVIII therapy after the companies conduct feasibility studies. Shire also made an equity investment into Rani Therapeutics as part of the collaboration.

    Get the full story at our sister site, Drug Delivery Business News.

    Appeal board to review Sanofi’s Lantus insulin injection patents

  • 7 medical devices combating the opioid crisis

    Opioid-related deaths have become an epidemic in the US, garnering attention from the White House, the FDA and many other governmental bodies. From 2000 to 2014, nearly half a million Americans died from drug overdoses. In 2015, more than 50,000 people died from a drug overdoses, and 33,000 were opioid-related. Prescription overdoses continue to cause […]

  • Companion Medical launches smart insulin pen in U.S.

    Companion Medical started selling its smart insulin pen in the U.S. today, according to the San Diego, Calif.-based company. The InPen system, which combines an insulin injector pen and a smartphone app, is compatible with Eli Lilly‘s (NYSE:LLY) Humalog and Novo Nordisk‘s (NYSE:NVO) Novolog fast-acting insulin. Get the full story at our sister site, Drug Delivery Business News. […]

  • Manufacturing companies form collaborative for advancing product development capabilities

    A group of manufacturing services companies said today they created a collaboration, called the Medical Device Development Collaborative, to help improve access to a full range of product development capabilities for concept-to-market solutions. The collaboration is based in the Medical Alley region and aims to help small to mid-size OEMs by offering experience and expertise […]

  • Millar offloads telemetry product line to Kaha Sciences

    Medical device and OEM company Millar said today it is selling its lifesciences telemetry product division to New Zealand-based Kaha Sciences. Houston-based Millar said the divestiture comes as the company looks to focus its efforts on the clinical and OEM business segments in a strategy that emerged earlier this year. Kaha Sciences has picked up a handful […]

  • InstruSafe and Senhance Surgical Robotic System partner to launch instrument trays

    Summit Medical’s InstruSafe and TransEnterix’s Senhance Surgical Robotic System  have forged a partnership to launch two new surgical instrument trays for use with the robotic platform. The two new trays will include an instrument tray an an endoscopic adapter tray, both of which have been validated for the Senhance instrumentation. “We are excited to expand our product offering […]

  • New FDA guidance for dual submission 510(k) and CLIA waiver application for IVD companies

    By Stewart Eisenhart, Emergo Group New guidance from the US Food and Drug Administration explains requirements for in vitro diagnostic manufacturers to register for premarket notification using the agency’s Dual 510(k) and Clinical Laboratory Improvement Amendments (CLIA) Waiver by Application. Get the full story here at the Emergo Group’s blog. The opinions expressed in this […]

  • Researchers create ultrasound-sensor powered prosthetic hand with individual digit control

    Researchers are one step closer to creating a prosthetic hand that allows users to have full control over each finger, according to a new report from Georgia Tech. Researchers at the university say they have created an ultrasonic sensor which allows amputees to control individual fingers on a prosthetic hand, with enough sensitivity to play […]

  • Medline acquires Centurion Medical Products

    Medline recently completed its previously announced acquisition of Centurion Medical Products – boosting offerings around the Medline Erase BSI line access and dressing change bundles. Financial terms of the deal were not disclosed. Medline’s Erase BSI is meant to standardize best practices around central lines post-insertion, reducing cases of bloodstream infections. On top of its minor procedure trays, Centurion makes vascular insertion […]

  • Cadence expands laser processing capabilities

    Cadence has expanded its laser processing technologies with a new CL900 Cincinnati laser cutting machine. The new 4,000W fiber laser cutter adds to Cadence’s modified tube cutting lasers and completely custom flat sheet cutting lasers, Cadence announced yesterday. It also has the ability to cut 1,000 in. per minute (IPM) with a positioning accuracy of +/-0.001 […]

  • These artificial heart muscle patches can repair dead heart muscles

    A team of biomedical engineers have developed a fully functioning artificial human heart muscle that can be used as a patch to repair dead heart muscle. Duke University biomedical engineers developed the patch to be used in human patients who have previously suffered a heart attack. “Right now, virtually all existing therapies are aimed at […]

  • How to think outside the box with medtech innovation

    Innovation is important in medtech and many other industries. But what does it really mean – and can it be done with speed? That was the question that a panel of experts – moderated by William Betten of Betten Solutions – grappled with today at DeviceTalks West in Orange County, Calif. It turns out that […]

  • Aerogen, Lyomark ink inhaled surfactant deal

    Share

    Aerogen, LyomarkAerogen and Lyomark Pharma said today that they inked a deal to develop an inhaled surfactant treatment for respiratory distress syndrome in pre-term infants.

    The pact calls for the duo to combine a compound called AP-002, a nasally inhaled surfactant based on a combination of Lyomark’s Alveofact bovine lung surfactant and Aerogen’s PDAP nasal delivery technology. Aerogen will develop the drug-device combo and the companies will cooperate on commercialization and distribution, they said.

    Get the full story at our sister site, Drug Delivery Business News.

    Court dismisses class action suits against Novocure

    Share

    NovocureTwo class action lawsuits filed against Novocure (NSDQ:NVCR) and some of its directors and executives in January were dismissed after the court established that it lacked personal jurisdiction over any of the defendants.

    In mid-January, Joseph Donahue, Stephen Rosen and Susan Rosen filed two putative class action suits in a New Hampshire court against Novocure, its directors, some of its officers and the underwriters of its October 2015 initial public offering. The plaintiffs alleged that the company misstated or omitted information in Novocure’s initial public offering materials, violating federal securities law.

    Get the full story at our sister site, Drug Delivery Business News.

    Acorda resubmits NDA for inhaled Parkinson’s disease therapy

  • Solvay releases new PEEK polymer for implantable devices

    Solvay has launched its new Zeniva ZA-600 CF30 polyetheretherketone (PEEK) designed for use in implantable device applications. Zeniva ZA-600 CF30 PEEK is a 30% carbon fiber-reinforced, radiolucent polymer that offers modulus that is similar to cortical bone. The polymer helps implants minimize bone density reduction while maintaining normal stress on surrounding bone tissues. The polymer […]

  • Lexington Biosciences moves forward with its affordable heart diagnostic device

    Lexington Biosciences (Vancouver, British Columbia) said today that it has brought on reimbursement experts as it seeks FDA clearance for its HeartSentry device. The strategic business relationship with a San Francisco arm of Chicago-based Navigant Consulting, is meant to help Lexington(CSE: LNB) (OTCQB: LXGTF) better work with relevant authorities to develop a coverage policy to support the commercial […]

  • Tobii and RightEye partner to create eye-tracking system

    RightEye and Tobii announced that they have forged a partnership to develop new hardware solutions for RightEye vision tests and training games for healthcare, vision and sports markets. “We’re excited to be partnering with Tobii to advance our product and offer customers a more portable, integrated eye-tracking system to further enhance their users’ experience with […]

  • How Smith & Nephew’s InVentures program is promoting innovation

    For nearly a decade, Smith & Nephew’s InVentures program has worked with surgeons who have innovative ideas but aren’t starting their own companies. The program provides a third innovation route on top of the major two for big medical device companies: internal R&D and acquisition of smaller companies with new technologies. “A company the size of Smith […]

  • Promenade Software to showcase medical device software at DeviceTalks West

    Promenade Software is a company comprised of highly skilled and experienced medical device software engineers with expertise spanning from low-level firmware to embedded applications, mobile applications and cloud services. Its engineers are on-site in Irvine, Calif. Featured technology and services: Parlay, professional services, cybersecurity Parlay: Parlay accelerates the development of medical device software, while simultaneously enabling testing and […]

  • Zeiss launches new imaging software

    Zeiss has launched its newest imaging software called the Zeiss Zen 2 core for improving laboratory workflow and efficiency. Zeiss Zen 2 core is a lab infrastructure solution designed to connect systems, data and workflows, helping laboratories become more efficient. The imaging software is used as a tool for image analysis and interactive control of […]

  • Overmolding: 2 types to know

    MTD Micromolding Some micro projects require specialty micro injection molding processes, such as overmolding. Overmolding involves two or more materials molded together to become one part. Examples include molding plastic over plastic or molding plastic over a preformed part, such as a metal insert. (See examples of common polymers and substrates below.) MTD specializes in […]

  • 3D printed organ models are getting way better: Here’s how

    University of Minnesota researchers are taking 3D printed organ models to the next level: They look and feel like the real thing, and integrated sensors help surgeons train. There’s even the potential that such artificial models may someday become the real deal – “bionic organs” used to replace damaged biological organs. The Minnesota researchers published […]

  • How BioSig is using plug and play as a medtech startup strategy

    Startups, as a rule, should have a plan for their technology to grow. But it is rare that a medical technology startup aims to be plug and play, fitting into many therapeutic areas from cardio to Alzheimer’s to diabetes. BioSig’s Pure EP, an electrophysiology signal recording and processing system, could potentially provide valuable insight during […]

  • PEEK formulations for new implantable devices

    Since the late 1990s, polyether ether ketone has become a go-to material for companies that manufacture orthopedic implants, thanks to its radiolucency and anatomical properties. Now, custom formulations of PEEK are enabling new potential applications for the polymer. Lawrence Acquarulo, Foster Corp. Polymers have always played a role in modern implantable medical devices. But until […]

  • Materialise and Formlabs want to bring more 3D printing labs to hospitals

    Materialise (Leuven, Belgium) and Formlabs (Somerville, Mass.) have forged a partnership to help deliver cost-effective solutions to hospitals that want to start in-house 3D printing labs. The partnership combines Materialise’s Mimics inPrint medical imaging software with Formlabs’s Form 2 printers to create a complete 3D printing package that will help implement patient-specific care that is an affordable price-per-print. Using […]